Healthcare • Biotechnology
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if QTTB is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
24 top institutions tracked
Last 13F trend: accumulating (heavy)
Unlock crowding heatmapUnlock filer discoverySentiment: bearish
Last trade: sell 48 days ago
Red flags: 17
70 filers reported a long position in QTTB for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| ORBIMED ADVISORS LLC | $52.6M | 4.1M | +83.2% |
| Boxer Capital Management, LLC | $40.1M | 3.1M | New |
| Atlas Venture Life Science Advisors, LLC | $34.6M | 2.7M | +29.9% |
| BVF INC/IL | $29.9M | 2.4M | New |
| RA CAPITAL MANAGEMENT, L.P. | $29.7M | 2.3M | New |
| Point72 Asset Management, L.P. | $14.9M | 1.2M | New |
| Opaleye Management Inc. | $11.9M | 931K | -25.9% |
| Logos Global Management LP | $10.2M | 800K | New |
| SummitTX Capital, L.P. | $9.3M | 733.8K | New |
| VANGUARD CAPITAL MANAGEMENT LLC | $6.6M | 518.8K | +69.3% |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.